These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14015861)

  • 1. [Preliminary study of Th-1321 or alpha-propylthioisonicotinamide in common pulmonary tuberculosis in man].
    BROUET G; CHEVALLIER J; NEVOT P
    Rev Tuberc Pneumol (Paris); 1962 Dec; 26():1187-203. PubMed ID: 14015861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
    Tamura M; Takano S
    Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of Th 1321 tolerance in the course of pulmonary tuberculosis].
    Brun J; Revol A; Moulinier J; Queneau P
    Mars Med; 1966; 103(11):795-9. PubMed ID: 5991811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our initial results of the utilization of Th 1321 in the treatment of pulmonary tuberculosis].
    Vidal J; Fourcade J; Guin JJ; Michel FB
    Mars Med; 1966; 103(11):801-6. PubMed ID: 5991812
    [No Abstract]   [Full Text] [Related]  

  • 5. [SUPPLEMENTARY CLINICAL STUDY OF ALPHA-PROPYL-ISONICOTINIC ACID THIOAMIDE (1321 TH)].
    BROUET G; CHEVALLIER J; MEEUS BITH L; NEVOT P
    Rev Tuberc Pneumol (Paris); 1965; 29():133-58. PubMed ID: 14326306
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE THIOAMIDE OF ALPHA-PROPYL-ISONICOTINIC ACID (OU 1321 TH) IN TREATMENT OF PULMONARY TUBERCULOSIS].
    MOLINA C; SIROT J; CHEMINAT JC; PETIT R
    Rev Tuberc Pneumol (Paris); 1964 Dec; 28():1261-88. PubMed ID: 14312958
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new antitubercular drug: 13-14 Th (thiamide of alpha-ethyl-isonicotinic acid)].
    ZURITA C
    Bol Cult Inf Cons Gen Col Med Esp; 1960 Feb; 23():17-23. PubMed ID: 13788980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of the antitubercular activity of an isonicotinic thioamide related to ethionamide: Th-1321 (RP-9.778)].
    NOUFFLARD-GUY-LOE H; BERTEAUX S
    Rev Tuberc Pneumol (Paris); 1962 Dec; 26():1204-15. PubMed ID: 13939067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitubercular agents. IV. Preparation of some derivatives on the nucleus of a substituted isonicotinic acid. II].
    Celadník M; Palát K; Novácek L; Matusková E; Kubala E; Pavlas M
    Cesk Farm; 1965 Aug; 14(6):303-7. PubMed ID: 5853851
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
    Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of alpha-propyl-isonicotinic acid thioamide or Th 1321 administered in association with minor antitubercular drugs].
    Miguères J; Layssol M; Jover A
    Rev Tuberc Pneumol (Paris); 1965 Dec; 29(12):1037-52. PubMed ID: 5865569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitubercular agents. 13. Functional derivatives of 2-halogen-6-ethylisonicotinic acid].
    Palát K; Zámocká J; Celadník M; Sova J; Kubala E
    Cesk Farm; 1974 May; 23(4):149-52. PubMed ID: 4830774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitubercular agents. XIX. Functional derivatives of 2-halogen-6-propylisonicotinic acid].
    Sova J; Celadník M; Waisser K; Kubala E; Palát K
    Cesk Farm; 1980 Aug; 29(6):196-20. PubMed ID: 7418017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antitubercular agents. XXIX. Functional derivatives of 2-methyl-5-iodoisonicotinic acid].
    Palát K; Celadník M; Dvorácková D; Kubala E
    Cesk Farm; 1983 Oct; 32(8):275-8. PubMed ID: 6652708
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PROBLEM OF THE IDENTIFICATION OF SOME ANTITUBERCULAR PREPARATIONS].
    SHILOV IuM; CHICHIRO VE
    Aptechn Delo; 1963; 12():65-8. PubMed ID: 14055392
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apropos of prothionamide. Monotherapy in 20 patients. Study of its tolerance in 89 patients].
    Lallemand M; Boutin C; Ohresser P; Gratecos L; Kleisbauer JP
    Mars Med; 1966; 103(11):807-14. PubMed ID: 5991813
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study in man of the variations in relation to time of the blood levels of prothionamide (1321 TH) and its sulfoxide (1406 TH) after rectal administration].
    Aiache JM; Cheminat JC; Ghaye-Roquet
    Sem Ther; 1967 Mar; 43(3):169-71. PubMed ID: 5601791
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro bactericidal activity of alpha-ethyl-isonicotinic acid thioamide].
    NITTI V; MEOLA G
    Riv Ist Sieroter Ital; 1959; 34():373-81. PubMed ID: 14427374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of lupus erythematosus with resochin and siluzide].
    DEMENKOVA NV
    Vestn Dermatol Venerol; 1963 Feb; 37():80-2. PubMed ID: 14026872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of rapid polarography with overimposed alternating current to the study of urinary elimination of ethionamide and prothionamide metabolites in humans].
    Bieder A; Brunel P
    Ann Pharm Fr; 1971; 29(9):461-75. PubMed ID: 5129579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.